APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
1 μg/mL |
1-5 μg/mL |
Assay dependent |
Not tested in other applications.
Calculated MW
Product Note
This antibody recognizes an epitope at the N-terminus of Chk2 (Checkpoint Kinase 2).
PROPERTIES
Form
Liquid
Buffer
PBS
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
Peptide corresponding to aa 1-50 of human Chk2.
Purification
Purified by antigen-affinity chromatography
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
CDS1 , CHEK2 , CHK2 , HuCds1 , LFS2 , PP1425 , RAD53 , checkpoint kinase 2 , hCds1 , Chk2
Cellular Localization
Nucleus,PML body,Nucleoplasm
Background
In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Database
Research Area
DATA IMAGES
|
GTX28108 ICC/IF Image
ICC/IF analysis of Jurkat cells using GTX28108 Chk2 antibody.
Dilution : 1 μg/ml.
|
|
GTX28108 ICC/IF Image
ICC/IF analysis of Jurkat cells using GTX28108 Chk2 antibody.
Red: Primary antibody
Blue: DAPI
|
|
GTX28108 WB Image
WB analysis of various samples using GTX28108 Chk2 antibody.
Land A : K562 whole cell lysateLane B : Jurkat whole cell lysate Lane C : HL-60 whole cell lysate
Dilution : 1 μg/ml.
|
REFERENCE
There are currently no references for Chk2 antibody (GTX28108). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for Chk2 antibody (GTX28108). Be the first to share your experience with this product.